IJN has been a speaker, consultant, and/or advisory board member for Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Bayer Pharmaceuticals, and MJH Life Sciences
Patient Education: Best Practices and Tools Education is essential to the success of any GLP1 clinic workflow
"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept." Cell Metabolism , 2022
Record side effects and adjust the dose rather than stopping abruptly
doi: 10.1016/j.diabet.2022.101344 76
The genesis of Nusaude Light lies in the quest to provide a healthy and long-lasting alternative for flawless and beautiful skin